Danaher tops forecasts as bioprocessing recovery fuels 2026 growth outlook
Danaher (NYSE:DHR) reported fourth-quarter results that surpassed Wall Street estimates on Wednesday, providing a bullish outlook for 2026 that suggests the long-awaited recovery in the bioprocessing and life sciences sectors is finally taking hold.




-640x358.jpg&w=3840&q=75)

-640x358.jpg&w=3840&q=75)

-640x358.jpg&w=3840&q=75)

